SCHEMBL27202083

SCHEMBL27202083

COc1ccc(NC(=O)c2nnc(C(F)(F)F)c(C(=O)c3ccccc3)c2N2CCNCC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.44
NPC1 O15118 2/20 0.44
ALDH1A1 P00352 6/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
GAA P10253 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPKAPK2 P49137 1/20 0.42
MAPT P10636 3/20 0.42
LMNA P02545 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
TP53 P04637 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
CDK2 P24941 1/20 0.40
FLT3 P36888 1/20 0.40
KMT2A Q03164 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27202080 0.84 ALDH1A1 (0.43) ALDH1A1GAACYP2C9HSD17B10
SCHEMBL27202096 0.81 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP2D6HSD17B10
SCHEMBL27202075 0.81 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2C9CYP2C19LMNA
SCHEMBL27202078 0.80 ALDH1A1 (0.39) ALDH1A1CYP1A2GAACYP2C19KDM4E
SCHEMBL27207054 0.77 PTGES (0.43) RAB9ANPC1ALDH1A1MAPKAPK2MAPT
SCHEMBL27202102 0.76 ALDH1A1 (0.37) ALDH1A1HSD17B10
SCHEMBL22495337 0.68 MAPT (0.79) RAB9ANPC1ALDH1A1MAPKAPK2MAPT
SCHEMBL27202089 0.67 ALDH1A1 (0.50) RAB9ANPC1ALDH1A1CYP3A4MAPT
SCHEMBL24619812 0.67 MAPKAPK2 (0.53) RAB9ANPC1ALDH1A1GAAMAPKAPK2
SCHEMBL29793177 0.67 MAPKAPK2 (0.53) RAB9ANPC1ALDH1A1GAAMAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP MGMT, MCL1, FANCF RAB9A 2634/4885NPC1 4062/4885ALDH1A1 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.